Avid Radiopharmaceuticals
avidrp.comTotal trials
54
Active
0
Phase 3
10
Total enrollment
6,830
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Alzheimer's Disease27
- Alzheimer Disease12
- Mild Cognitive Impairment6
- Parkinson's Disease3
- Alzheimers Disease3
- Type 2 Diabetes2
- Frontotemporal Dementia2
- Neurodegenerative Diseases2
Frequently asked questions about Avid Radiopharmaceuticals
- How many clinical trials does Avid Radiopharmaceuticals have on ClinicalTrials.gov?
- Avid Radiopharmaceuticals is listed as the lead sponsor on 54 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Avid Radiopharmaceuticals's trials are in Phase 3?
- 10 of Avid Radiopharmaceuticals's trials are in Phase 3.
- What therapeutic areas does Avid Radiopharmaceuticals focus on?
- Avid Radiopharmaceuticals's most-studied conditions on ClinicalTrials.gov are Alzheimer's Disease, Alzheimer Disease, Mild Cognitive Impairment, Parkinson's Disease, Alzheimers Disease.